Griffin Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,678
| Closed | -$1.37M | – | 214 |
|
|
2024
Q2 | $1.37M | Sell |
16,678
-760
| -4% | -$62.6K | 0.16% | 113 |
|
|
2024
Q1 | $1.52M | Sell |
17,438
-35
| -0.2% | -$3.06K | 0.18% | 109 |
|
|
2023
Q4 | $1.68M | Buy |
17,473
+453
| +3% | +$43.7K | 0.21% | 98 |
|
|
2023
Q3 | $1.51M | Hold |
17,020
| – | – | 0.21% | 101 |
|
|
2023
Q2 | $1.48M | Buy |
17,020
+2,175
| +15% | +$189K | 0.2% | 108 |
|
|
2023
Q1 | $1.44M | Sell |
14,845
-111
| -0.7% | -$10.8K | 0.2% | 106 |
|
|
2022
Q4 | $1.55M | Buy |
+14,956
| New | +$1.55M | 0.23% | 103 |
|
|
2022
Q2 | – | Sell |
-4,640
| Closed | -$358K | – | 215 |
|
|
2022
Q1 | $358K | Sell |
4,640
-7,330
| -61% | -$566K | 0.05% | 182 |
|
|
2021
Q4 | $1.06M | Buy |
11,970
+540
| +5% | +$47.7K | 0.13% | 141 |
|
|
2021
Q3 | $883K | Sell |
11,430
-485
| -4% | -$37.5K | 0.11% | 149 |
|
|
2021
Q2 | $994K | Sell |
11,915
-1,735
| -13% | -$145K | 0.12% | 142 |
|
|
2021
Q1 | $1.03M | Buy |
13,650
+2,365
| +21% | +$179K | 0.13% | 134 |
|
|
2020
Q4 | $990K | Buy |
11,285
+210
| +2% | +$18.4K | 0.13% | 126 |
|
|
2020
Q3 | $843K | Buy |
11,075
+305
| +3% | +$23.2K | 0.13% | 123 |
|
|
2020
Q2 | $1.33M | Sell |
10,770
-75
| -0.7% | -$9.25K | 0.21% | 92 |
|
|
2020
Q1 | $916K | Buy |
+10,845
| New | +$916K | 0.17% | 104 |
|
|
2019
Q3 | – | Sell |
-235
| Closed | -$20K | – | 257 |
|
|
2019
Q2 | $20K | Buy |
+235
| New | +$20K | ﹤0.01% | 425 |
|